Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suppository containing chlorpheniramine maleate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing chlorpheniramine are listed in tablet and suspension forms. No finished chlorpheniramine product of any kind is listed in suppository form.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Chlorpheniramine is a first-generation, sedating antihistamine; compounding pharmacies prepare it as oral liquids and capsules by prescription.
Chlorpheniramine maleate is a first-generation H1 antihistamine. It blocks histamine at H1 receptors, and because first-generation agents are lipophilic and cross into the brain, it causes drowsiness and anticholinergic effects. Manufactured chlorpheniramine products are sold over the counter: single-ingredient tablets such as Aller-Chlor (Rugby Laboratories) are labeled to temporarily relieve sneezing, runny nose, itchy watery eyes and itching of the nose or throat from hay fever or other upper respiratory allergies, and many multi-symptom cold products combine it with other ingredients. Prescribers may order chlorpheniramine compounded when a patient needs a strength, flavor or dye-free vehicle that is not manufactured, or a combination with another ingredient. Compounded preparations are not FDA-approved and require a prescription.
The Drug Facts label carries no boxed warning. It warns not to use chlorpheniramine to make a child sleepy, and its directions say not to give it to children under 6. Ask your prescriber first if you have glaucoma, a breathing problem such as emphysema or chronic bronchitis, or trouble urinating from an enlarged prostate, or take sedatives or tranquilizers. Drowsiness is common, and alcohol, sedatives and tranquilizers add to it, so take care driving; excitability can occur, especially in children. MedlinePlus notes that adults 65 and older usually should not take it and that combination cold products can double up the same ingredient. LactMed says small, occasional doses are acceptable while breastfeeding, but larger or longer use may affect the infant or reduce milk supply; for pregnancy, the label says to ask a health professional. For vision problems, trouble urinating or other side effects, talk to your prescriber or pharmacist.
Chlorpheniramine is a first-generation H1-receptor antagonist. StatPearls describes first-generation agents as highly lipophilic, crossing the blood-brain barrier to cause sedation, psychomotor impairment and anticholinergic adverse events, and lists second-generation agents as preferred. StatPearls describes first-generation antihistamines as a class as rapidly absorbed orally, hepatically metabolized and renally excreted, with elimination that may be prolonged in older adults and in hepatic or renal impairment; it gives no chlorpheniramine-specific values. Labeled use (OTC Drug Facts, Aller-Chlor): temporary relief of upper respiratory allergy symptoms; the label warns against use in children under 6. Dosing and vehicle are per prescriber. Monitor for sedation, anticholinergic effects such as urinary retention and vision problems, additive CNS depression with alcohol, sedatives or tranquilizers, and paradoxical excitation in children. LactMed names cetirizine, desloratadine, fexofenadine, levocetirizine and loratadine as alternatives to consider during breastfeeding. Chlorpheniramine is not a controlled substance.
Wash your hands. If the suppository is soft, chill it in its wrapper in the refrigerator or under cool water for a few minutes, then unwrap it. For rectal use, coat the tip with a water-soluble lubricant (not petroleum jelly), lie on your side with your upper knee bent, and insert it pointed end first past the muscle at the opening. For vaginal use, lie on your back with knees bent and insert it as far as it comfortably goes, by finger or applicator; bedtime use limits leakage, and a panty liner protects clothing. Stay lying down about 15 minutes. Wash your hands.
Suppositories are nonaqueous, so under USP <795> they can carry a beyond-use date of up to 180 days at controlled room temperature or in the refrigerator when no other stability data apply. Storage depends on the base: fatty bases can soften at room temperature and may be labeled for the refrigerator, while polyethylene glycol bases usually do not need refrigeration. Keep them cool so they do not melt, and refrigerate them if your label says to.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
